Sign in

You're signed outSign in or to get full access.

Lauralee E. Martin

Director at Marcus & MillichapMarcus & Millichap
Board

About Lauralee E. Martin

Independent Class II Director at Marcus & Millichap, Inc. (MMI) since 2019; age 74. Former CEO and President of Healthpeak Properties, Inc. (formerly HCP; now DOC); prior senior roles at Jones Lang LaSalle (CFO; COO/CFO; CEO, Americas) and Heller Financial. Serves on MMI’s Audit Committee (designated an “audit committee financial expert”) and Executive Committee; determined independent under NYSE and SEC rules. Education: B.A., Oregon State University; M.B.A., University of Connecticut. Current term expires at the 2027 annual meeting.

Past Roles

OrganizationRoleTenureCommittees/Impact
Healthpeak Properties, Inc. (DOC; formerly HCP)Chief Executive Officer and PresidentOct 2013 – Jul 2016Led REIT focused on healthcare real estate
Jones Lang LaSalle, Inc.CEO, Americas DivisionJan 2013 – Oct 2013Ran Americas operations for global real estate services firm
Jones Lang LaSalle, Inc.EVP & CFO; later COO & CFOJan 2002 – Jan 2013 (CFO through Oct 2005; COO/CFO Oct 2005–Jan 2013)Finance, operations, investor relations, banking relationships
Heller Financial, Inc.VP; CFO; Senior Group President; President, Real Estate Group15 years (dates not individually specified)Led real estate finance group; broad commercial finance leadership

External Roles

OrganizationRoleTenureNotes
Kaiser Aluminum CorporationDirectorCurrentPublic company directorship
QuadReal Property GroupDirectorCurrentGlobal real estate investment firm
Beacon Capital PartnersAdvisorCurrentAdvisor to private real estate investment firm
Healthpeak Properties, Inc.Former DirectorPriorPrior board service
ABM IndustriesFormer DirectorPriorPrior board service
KeyCorpFormer DirectorPriorPrior board service
Gables Residential TrustFormer DirectorPriorPrior board service

Board Governance

  • Independence: Board determined Ms. Martin is independent under NYSE/SEC standards. She serves on independent standing committees.
  • Committees: Audit Committee member (Audit Chair: Norma J. Lawrence); designated an “audit committee financial expert.” Executive Committee member (Executive Chair: George M. Marcus).
  • Attendance and engagement: In 2024, Board held 5 meetings; Audit held 4; Executive held 1. No director attended fewer than 75% of Board/committee meetings; average committee attendance reported as 100%.
  • Board structure: Separate Chair (George M. Marcus), Lead Independent Director (Don C. Watters), and CEO (Hessam Nadji). Class II director; term ends at 2027 meeting.
  • Shareholder alignment policies: Stock ownership guidelines for directors; prohibition on hedging and pledging; compensation recovery policy for executives.

Fixed Compensation

Component (Director)Amount / DetailEvidence
2024 Cash Fees (actual)$85,000
2024 Equity Grant (grant-date value)$74,986
2024 Total Director Comp (cash + equity)$159,986
Annual Board cash retainer (policy)$65,000
Audit Committee member fee (policy)+$10,000 (member); +$20,000 (chair)
Executive Committee member fee (policy)+$10,000 (independent members)
Annual director equity (policy)$75,000 in restricted stock; one-year vest
Ownership guideline (director)5x annual cash retainer; all directors met guideline as of Mar 12, 2025

Note: Ms. Martin’s $85,000 cash fees align with policy rates for Board retainer ($65,000), Audit member ($10,000), and independent Executive Committee member ($10,000).

Performance Compensation

Grant DateAward TypeShares GrantedGrant-Date Fair ValueVesting
May 2, 2024Restricted Stock2,303$74,986Vests on earlier of first anniversary or next annual meeting
  • No director performance awards (no options/PSUs for directors); equity is time-based restricted stock with one-year vesting.

Other Directorships & Interlocks

CompanyRoleInterlock/Conflict Note
Kaiser Aluminum CorporationDirectorNo MMI-related transactions disclosed involving Ms. Martin.
QuadReal Property GroupDirectorNo MMI-related transactions disclosed involving Ms. Martin.
Beacon Capital PartnersAdvisorNo MMI-related transactions disclosed involving Ms. Martin.
Prior: Healthpeak, ABM Industries, KeyCorp, Gables Residential TrustFormer DirectorHistorical roles; no current MMI conflicts disclosed.

Expertise & Qualifications

  • Real estate services leadership (CEO of Healthpeak; CEO Americas and COO/CFO at JLL); extensive acquisition evaluation and investor relations.
  • Finance and accounting depth; designated “audit committee financial expert.”
  • Banking and capital markets experience; managed banking relationships at JLL/Heller.
  • Education: B.A. (Oregon State University); M.B.A. (University of Connecticut).

Equity Ownership

MetricAmount
Total beneficial ownership13,556 shares (includes 2,303 restricted shares vesting May 1, 2025)
% of shares outstanding~0.035% (13,556 / 39,198,040 outstanding)
Vested vs. unvested2,303 shares subject to vesting as of year-end/record date window; remainder held outright
Pledged or hedged sharesNone disclosed for Ms. Martin; directors prohibited from hedging/pledging under policy

Governance Assessment

Strengths

  • Independent director with deep real estate services and finance operating experience; designated audit committee financial expert.
  • Strong engagement/attendance culture: no director below 75% in 2024; committees reported 100% average attendance.
  • Alignment mechanisms: meaningful equity component ($74,986 restricted stock) and 5x retainer stock ownership guideline met by all directors as of March 12, 2025.
  • Risk controls: prohibitions on hedging/pledging, independent committee structures, compensation recovery policy for executives.

Watch items and context for investors

  • Concentrated control/insider influence at the company level: Chair George M. Marcus beneficially owns 38.3% and 3.5 million shares at Phoenix are pledged as collateral (systemic governance consideration; not specific to Ms. Martin).
  • Executive Committee authority is broad (may act on matters including administering stock plans); however, Ms. Martin’s presence as an independent member supports oversight.
  • 2024 say‑on‑pay support fell to ~71% (vs. ~93% in 2023), prompting changes to add PSUs in 2025; shows active shareholder scrutiny of pay practices (context, not director‑specific).

Related‑party transactions and conflicts

  • Company has ongoing related‑party ties to Marcus & Millichap Company (MMC) (services, fees, lease) due to legacy structure; 2024 transactions disclosed. No transactions involving Ms. Martin identified above $25,000 since Jan 1, 2024.

Director compensation structure quality

  • Balanced mix of cash ($85,000) and equity ($74,986) with one‑year vest and no performance awards or perquisites; stockholder‑approved $500,000 annual director cap.